Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

FHS
July 1, 2024
1:41 pm

Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the aggressive form of skin cancer, Merkel cell carcinoma.

FDA OKs Amivantamab as First-Line Lung Cancer Treatment

The FDA approved amivantamab (Rybrevant) plus combination chemotherapy for the first-line treatment of non-small cell lung cancer (NSCLC) in patients whose tumors harbor EGFR exon

March 5, 2024

Study finds non-nutritive sweetened beverages more effective than water for weight loss

The effects of consuming non-nutritive sweetened (NNS) beverages and water after a weight management program.

October 9, 2023

Is HPV infection a hidden risk factor for prostate cancer?

In a comprehensive meta-analysis published in Scientific Reports, researchers unveil a significant link between human papillomavirus (HPV) infection and increased risk of prostate cancer, highlighting

October 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.